Sub menu

 
 

Orencia (abatacept) subcutaneous medicines shortages have resolved

Published

The pharmaceutical company Bristol-Myers Squibb Australia (BMS) has notified us that the shortages of both abatacept subcutaneous presentations have resolved. Supply has returned to normal. 

Go to the Medicine Shortage Reports Database- external site- external site for details.

Topics
Featured in

This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/orencia-abatacept-subcutaneous-medicines-shortages-have-resolved

Help us improve the Therapeutic Goods Administration site